STATE STREET CORP - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$26,000
-98.2%
53,121
-95.2%
0.00%
Q1 2019$1,469,000
+3.7%
1,095,945
-12.6%
0.00%
Q4 2018$1,417,000
-57.3%
1,254,377
+4.2%
0.00%
Q3 2018$3,322,000
-19.4%
1,203,672
+4.2%
0.00%
Q2 2018$4,124,000
+19.1%
1,155,590
+2.4%
0.00%
Q1 2018$3,464,000
-42.6%
1,128,581
+17.8%
0.00%
Q4 2017$6,034,000
-5.1%
957,890
+3.0%
0.00%
-100.0%
Q3 2017$6,361,000
+23.2%
930,274
+28.3%
0.00%
Q2 2017$5,165,000
-17.6%
725,094
+6.4%
0.00%
-100.0%
Q1 2017$6,265,000
+118.8%
681,533
-4.1%
0.00%
Q4 2016$2,864,000
+6.9%
710,982
+1.6%
0.00%
Q3 2016$2,679,000
-10.4%
699,591
+0.6%
0.00%
Q2 2016$2,989,000
-6.8%
695,480
+0.5%
0.00%
Q1 2016$3,206,000
-76.6%
691,905
-49.5%
0.00%
-100.0%
Q4 2015$13,729,000
-49.7%
1,369,560
-62.6%
0.00%
-33.3%
Q3 2015$27,319,000
-57.7%
3,662,875
+169.4%
0.00%
-57.1%
Q2 2015$64,523,000
+23.5%
1,359,796
-4.6%
0.01%
+40.0%
Q1 2015$52,233,000
+8.3%
1,425,547
+17.3%
0.01%0.0%
Q4 2014$48,244,000
+796.4%
1,214,921
+350.5%
0.01%
+400.0%
Q3 2014$5,382,000
+64.4%
269,689
+11.2%
0.00%
Q2 2014$3,273,000
+89.6%
242,604
+53.1%
0.00%
Q1 2014$1,726,000
+9.9%
158,484
+36.3%
0.00%
Q4 2013$1,571,000
+90.7%
116,258
+61.0%
0.00%
Q3 2013$824,000
+402.4%
72,212
+211.3%
0.00%
Q2 2013$164,00023,2000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders